Physicians' acceptable treatment failure rates in antibiotic therapy for coagulase-negative staphylococcal catheter-associated bacteremia: Implications for reducing treatment duration

Clinical Infectious Diseases

Volumn 41, Issue 12, 2005, Pages 1734-1741

  Perencevich, Eli H ^a,e   Harris, Anthony D ^a   Kaye, Keith S ^b   Bradham, Douglas D ^a   Fisman, David N ^c   Liedtke, Laura A ^d   Strausbaugh, Larry J ^d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DREXEL UNIVERSITY   (United States)

^d PORTLAND VA MEDICAL CENTER   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; METICILLIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; BACTERIAL VIRULENCE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; COAGULASE NEGATIVE STAPHYLOCOCCUS; COHORT ANALYSIS; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETERIZATION; EQUIPMENT CONTAMINATION; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; STAPHYLOCOCCAL INFECTIONS; TIME FACTORS; TREATMENT FAILURE;

EID: 28744435574     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/498116     Document Type: Article

References (40)

1. Levy SB. Confronting multidrug resistance: a role for each of us. JAMA 1993; 269:1840-2.
2. Fiscella K, Franks P, Zwanziger J, Mooney C, Sorbero M, Williams GC. Risk aversion and costs: a comparison of family physicians and general internists. J Fam Pract 2000; 49:12-7.
3. Pearson SD, Goldman L, Orav EJ, et al. Triage decisions for emergency department patients with chest pain: do physicians' risk attitudes make the difference? J Gen Intern Med 1995; 10:557-64.
4. Perencevich EN, Kaye KS, Strausbaugh LJ, Fisman DN, Harris AD. Acceptable rates of treatment failure in osteomyelitis involving the diabetic foot: a survey of infectious diseases consultants. Clin Infect Dis 2004; 38:476-82.
5. Arrow K, Solow R, Portney P, Learner E, Radner R, Schuman H. Report of the NOAA Panel on Contingent Valuation. Washington, DC: National Oceanic and Atmospheric Administration, 1993. Available at: http://www.darp.noaa.gov/ library/pdf/cvblue.pdf. Accessed 20 October 2005.
6. Strausbaugh LJ, Jernigan DB, Liedtke LA. National shortages of antimicrobial agents: results of 2 surveys from the Infectious Diseases Society of America Emerging Infections Network. Clin Infect Dis 2001; 33:1495-501.
7. Lockhart PB, Brennan MT, Fox PC, Norton HJ, Jernigan DB, Strausbaugh LJ. Decision-making on the use of antimicrobial prophylaxis for dental procedures: a survey of infectious disease consultants and review. Clin Infect Dis 2002; 34:1621-6.
8. Avorn J, Soumerai SB, Taylor W, Wessels MR, Janousek J, Weiner M. Reduction of incorrect antibiotic dosing through a structured educational order form. Arch Intern Med 1988; 148:1720-4.
9. Goldmann DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: a challenge to hospital leadership. JAMA 1996; 275:234-40.
10. Duncan RA. Controlling use of antimicrobial agents. Infect Control Hosp Epidemiol 1997; 18:260-6.
11. McGowan JE Jr. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol 1994; 15:478-83.
12. Pestotnik SL, Classen DC, Evans RS, Burke JP. Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med 1996; 124:884-90.
13. Gonzales R, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med 2001; 134:479-86.
14. Cooper RJ, Hoffman JR, Bartlett JG, et al. Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med 2001; 134:509-17.
15. Hickner JM, Bartlett JG, Besser RE, Gonzales R, Hoffman JR, Sande MA. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med 2001; 134:498-505.
16. Gonzales R, Sande MA. Uncomplicated acute bronchitis. Ann Intern Med 2000; 133:981-91.
17. Centers for Disease Control and Prevention. Vancomycin-resistant Staphylococcus aureus-Pennsylvania, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:902.
18. Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin-United States, 2002. MMWR Morb Mortal Wkly Rep 2002; 51:565-7.
19. Centers for Disease Control and Prevention. Vancomycin-resistant Staphylococcus aureus-New York, 2004. MMWR Morb Mortal Wkly Rep 2004; 53:322-3.
20. Centers for Disease Control and Prevention. 12 Steps to prevent antimicrobial resistance among hospitalized adults: campaign to prevent antimicrobial resistance in healthcare settings. Atlanta, GA: US Centers for Disease Control and Prevention (CDC), 2003. Available at: http:/ /www.cdc.gov/drugresistance/health care/ha/12steps_HA.htm. Accessed 3 November 2004.
21. Sunenshine RH, Liedtke LA, Jernigan DB, Strausbaugh LJ. Role of infectious diseases consultants in management of antimicrobial use in hospitals. Clin Infect Dis 2004; 38:934-8.
22. Centers for Disease Control and Prevention. Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin. JAMA 1997; 278:461-2.
23. Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995; 16:105-13.
24. [erratum: Infect Control Hosp Epidemiol 1995; 16:498].
25. Klose T. The contingent valuation method in health care. Health Policy 1999; 47:97-123.
26. Hammond JS, Keeney RL, Raiffa H. The hidden traps in decision making. Clin Lab Manage Rev 1999; 13:39-47.
27. Fisman DN, Mittleman MA, Sorock GS, Harris AD. Willingness to pay to avoid sharps-related injuries: a study in injured health care workers. Am J Infect Control 2002; 30:283-7.
28. Neumann PJ, Johannesson M. The willingness to pay for in vitro fertilization: a pilot study using contingent valuation. Med Care 1994; 32:686-99.
29. Lee SJ, Neumann PJ, Churchill WH, Cannon ME, Weinstein MC, Johannesson M. Patients' willingness to pay for autologous blood donation. Health Policy 1997; 40:1-12.
30. Lee SJ, Liljas B, Neumann PJ, Weinstein MC, Johannesson M. The impact of risk information on patients' willingness to pay for autologous blood donation. Med Care 1998; 36:1162-73.
31. Zillich AJ, Blumenschein K, Johannesson M, Freeman P. Assessment of the relationship between measures of disease severity, quality of life, and willingness to pay in asthma. Pharmacoeconomics 2002; 20: 257-65.
32. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32: 1249-72.
33. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999; 29:239-44.
34. Raad I, Davis S, Khan A, Tarrand J, Elting L, Bodey GP. Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremia. Infect Control Hosp Epidemiol 1992; 13:215-21.
35. Jantausch BA, Deville J, Adler S, et al. Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens. Pediatr Infect Dis J 2003; 22: S164-71.
36. Kaplan SL, Deville JG, Yogev R, et al. Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children. Pediatr Infect Dis J 2003; 22:677-86.
37. Raad I, Darouiche R, Vazquez J, et al. Efficacy and safety of weekly dalbavancin therapy for catheter-related bloodstream infection caused by gram-positive pathogens. Clin Infect Dis 2005; 40:374-80.
38. Lipsky BA, Berendt AR, Deery HG, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004; 39:885-910.
39. Butler CC, Kinnersley P, Prout H, Rollnick S, Edwards A, Elwyn G. Antibiotics and shared decision-making in primary care. J Antimicrob Chemother 2001; 48:435-40.
40. Elwyn G, Gwyn R, Edwards A, Grol R. Is 'shared decision-making' feasible in consultations for upper respiratory tract infections? Assessing the influence of antibiotic expectations using discourse analysis. Health Expect 1999; 2:105-17.